Ancylostoma caninum Hookworm Infection in Dogs: Clinical Signs, Diagnosis, and Treatment

Introduction

Ancylostoma caninum is a blood-feeding nematode parasite of the small intestine of dogs and is considered one of the most pathogenic gastrointestinal helminths of canids worldwide [1, 2]. The parasite belongs to the family Ancylostomatidae and is characterized by a large buccal capsule armed with cutting teeth that facilitate attachment to the intestinal mucosa and submucosa [3]. Infection with A. caninum results in hemorrhagic enteritis, iron deficiency anemia, and protein-losing enteropathy, particularly in young puppies [4]. In recent years, the emergence of multidrug-resistant (MDR) A. caninum populations has complicated clinical management and prompted a reevaluation of diagnostic and therapeutic paradigms [1, 5, 6, 7]. This article provides an exhaustive review of the clinical signs, diagnostic modalities, and treatment strategies for A. caninum infection in dogs, with emphasis on contemporary molecular diagnostics and anthelmintic resistance.

Life Cycle and Transmission

The life cycle of A. caninum is direct. Adult worms reside in the small intestine, where females produce eggs that are shed in feces [3]. Under favorable environmental conditions (warmth, moisture, shade), eggs embryonate and hatch into first-stage (L1) larvae, which molt twice to become third-stage (L3) infective larvae [3]. Transmission to dogs occurs via three main routes: percutaneous penetration of L3 larvae, oral ingestion of L3 larvae, and transmammary transfer to nursing puppies via colostrum or milk [8, 4]. Prenatal (transplacental) transmission is not a significant route for A. caninum, in contrast to Toxocara canis [9]. Hypobiosis (larval arrest) can occur in canine tissues, particularly in adult immune-competent dogs, and reactivation during late pregnancy can lead to lactogenic transmission [8]. Experimental studies have confirmed that topical application of macrocyclic lactone-containing products to pregnant bitches can reduce lactogenic transmission [8].

The prepatent period for A. caninum is approximately 14 to 21 days, though percutaneously acquired infections may have a slightly shorter prepatent period [10]. Environmental contamination is sustained by high egg output from infected dogs, with egg counts often exceeding 10,000 eggs per gram (EPG) of feces in heavily infected individuals [11].

Clinical Signs

Clinical manifestations of A. caninum infection vary with the intensity of the worm burden, host age, and nutritional status. Puppies are most severely affected. Acute infection in young puppies can cause profound blood loss anemia due to the combined effects of active blood feeding (each adult worm consumes up to 0.1 mL of blood per day) and persistent bleeding from attachment sites [3, 4]. Clinical signs include pale mucous membranes, lethargy, weakness, poor body condition, and dark, tarry feces (melena) resulting from digested blood [4]. Severe infections may lead to hypoproteinemia, ascites, and death [4].

In adult dogs, chronic subclinical infections are common; however, significant anemia and weight loss can occur in cases of high worm burden or concurrent disease [12]. A study of subclinically infected female dogs demonstrated alterations in serum biochemical analytes, including decreased total protein, albumin, and iron concentrations, and increased acute-phase proteins [12]. Experimentally infected dogs have shown elevations in inflammatory markers during the acute phase, followed by a gradual recovery of hematological parameters [13].

Dermatitis (ground itch) can occur at the site of percutaneous larval penetration, manifesting as erythematous papules and pruritus, particularly in dogs with repeated exposure [3]. In the context of parasite co-infections, clinical signs may be compounded by other enteric pathogens such as Trichuris vulpis or Giardia spp. [14, 15].

Diagnosis

Diagnosis of A. caninum infection relies on detection of eggs in fecal samples, species-specific molecular assays, and, less commonly, serological testing.

Fecal Flotation and Microscopy

Centrifugal fecal flotation using solutions of high specific gravity (e.g., zinc sulfate or Sheather's sugar solution; specific gravity 1.18–1.30) is the standard method for detecting hookworm eggs [11]. Ancylostoma caninum eggs are oval, thin-shelled, and measure approximately 55–75 µm × 34–45 µm, with a segmented morula at the time of shedding [2]. Sensitivity is improved by performing centrifugal flotation rather than passive flotation, and by using larger sample volumes [11]. A study comparing a broad quantitative PCR (qPCR) panel with centrifugal flotation found qPCR to be significantly more sensitive for detecting A. caninum, especially in samples with low egg counts [11]. Nevertheless, flotation remains a cost-effective initial screening tool.

Morphological identification of hookworm eggs to the species level is difficult because A. caninum, A. braziliense, and Uncinaria stenocephala produce similarly sized eggs [2]. Molecular methods are necessary for accurate species differentiation, particularly in regions where multiple hookworm species coexist [2].

Molecular Diagnostics: PCR and qPCR

Species-specific conventional and quantitative PCR assays have been developed targeting the internal transcribed spacer (ITS) regions of ribosomal DNA, the cytochrome c oxidase subunit 1 (cox1) mitochondrial gene, and other genomic regions [11, 16, 17]. A high-throughput multiplex qPCR panel that includes A. caninum has demonstrated excellent sensitivity and specificity in clinical fecal samples, with a limit of detection equivalent to approximately 5 EPG [11]. Multiplex ARMS-qPCR methods allow simultaneous detection and differentiation of A. caninum and other hookworm species in a single reaction [16]. T-m-Shift assays, based on melting temperature differences, have also been developed for rapid discrimination between A. caninum and A. ceylanicum [17].

Drug Resistance Marker Detection

The emergence of multidrug resistance in A. caninum, particularly to benzimidazoles and macrocyclic lactones, has driven the development of molecular markers for resistance detection [18, 19]. Single nucleotide polymorphisms (SNPs) in the β-tubulin isotype 1 gene (codons 167, 198, and 200) are associated with benzimidazole resistance in several nematodes, including A. caninum [18]. A novel fecal PCR assay targeting these SNPs can detect resistance alleles directly from fecal samples, permitting rapid identification of resistant populations [18]. Such assays have been applied to clinical cases in dogs from Canada and the United States, confirming the presence of benzimidazole-resistant A. caninum in multiple geographic locations [19, 5].

Serological Diagnosis

Secretory products of adult A. caninum, including cysteine protease-like proteins, have been characterized for their potential as diagnostic antigens [20]. However, serological assays are not used routinely for diagnosis of patent infections in dogs, as they cannot distinguish between current infection and prior exposure. Most diagnostic protocols rely primarily on coprological methods.

Hematological and Biochemical Findings

Ancillary diagnostic findings in dogs with hookworm disease include normocytic, normochromic anemia (later becoming microcytic, hypochromic as iron deficiency develops), eosinophilia (variable), and hypoalbuminemia [12, 13]. Serum iron concentrations and total iron-binding capacity can be useful indicators of iron deficiency secondary to chronic blood loss [12].

The following table summarizes the strengths and limitations of the major diagnostic methods.

Treatment and Anthelmintic Resistance

Historical Treatment Approaches

Historically, A. caninum infections were effectively treated with benzimidazoles (e.g., fenbendazole), pyrantel pamoate, macrocyclic lactones (e.g., milbemycin oxime, moxidectin), and combination products. Single doses of pyrantel pamoate (5 mg/kg) provided high efficacy against adult worms, while milbemycin oxime (0.5 mg/kg) showed efficacy against both adult and larval stages [21, 22, 23]. Fenbendazole administered to pregnant bitches at 50 mg/kg for 3 consecutive days was shown to reduce prenatal and lactogenic transmission of A. caninum to pups [9]. Moxidectin sustained-release injectable formulations demonstrated persistent efficacy against experimental infections for up to 90 days [24].

Emergence of Multidrug Resistance

Repeated reports of treatment failures in greyhound kennels and breeding facilities, particularly in the southeastern United States, led to the confirmation of multidrug resistance in A. caninum [5, 6, 7]. Isolates from Georgia, Florida, and other states were found to be resistant to all three major anthelmintic classes: benzimidazoles (fenbendazole), macrocyclic lactones (milbemycin oxime, moxidectin), and tetrahydropyrimidines (pyrantel pamoate) [5, 6, 7]. Laboratory confirmation using fecal egg count reduction tests (FECRT) and controlled anthelmintic efficacy studies demonstrated that some isolates showed less than 80% reduction in egg counts after labeled doses of multiple drugs [6]. The molecular basis of macrocyclic lactone resistance is less well understood but believed to involve alterations in glutamate-gated chloride channels and P-glycoprotein efflux pumps [1].

Current Treatment Protocols in the Resistance Era

In response to MDR hookworms, the American Association of Veterinary Parasitologists (AAVP) Hookworm Task Force has published best-practice recommendations [1]. Key principles include:

1. Use of combination products containing two or more active ingredients with different mechanisms of action. Newer oral combination products that include lotilaner (an isoxazoline) plus moxidectin and pyrantel (e.g., Credelio Quattro) have shown high efficacy against both sensitive and some resistant hookworm isolates [25]. Another combination product containing milbemycin oxime and lotilaner (Credelio Plus) demonstrated efficacy against larval and immature adult stages of A. caninum [26]. Similarly, formulations of sarolaner, moxidectin, and pyrantel (Simparica Trio) are effective against induced hookworm infections [10].

2. Repeated dosing at intervals shorter than the recommended monthly frequency. For resistant cases, treatment every 2 to 4 weeks for several cycles may be necessary to reduce worm burdens [1].

3. Fecal egg count reduction testing (FECRT) to confirm anthelmintic efficacy. A reduction of less than 90% in EPG 10–14 days post-treatment indicates resistance [1].

4. Environmental management: prompt removal of feces, avoiding overcrowding, and maintaining clean, dry kennel surfaces [1, 27].

A survey of U.S. veterinarians revealed variable awareness of hookworm resistance and inconsistent implementation of best practices, underscoring the need for continued education [27].

The following Mermaid diagram illustrates a diagnostic and treatment decision workflow for suspect hookworm infection.

flowchart TD
    A[Dog with clinical signs or risk factors] --> B[Fecal centrifugal flotation / qPCR panel]
    B --> C{Positive for Ancylostoma caninum?}
    C -->|No| D[Rule out other causes]
    C -->|Yes| E[Identify anthelmintic history & risk for resistance]
    E --> F[Perform FEC on fresh sample]
    F --> G[Administer combination anthelmintic therapy]
    G --> H[Repeat FEC in 10-14 days]
    H --> I{FEC reduction <90%?}
    I -->|No| J[Continue monthly prevention + monitoring]
    I -->|Yes| K[Suspect multidrug resistance]
    K --> L[Perform benzimidazole resistance qPCR]
    L --> M[Consider off-label higher doses, frequent dosing, or environmental decontamination]
    M --> N[Recheck FEC after 2-4 weeks of intensified protocol]
    N --> O{EPG near zero?}
    O -->|Yes| J
    O -->|No| P["Consult specialist; consider combination therapy with extended interval"]

Prevention and Control

Prevention of A. caninum infection in dogs relies on year-round administration of broad-spectrum heartworm prevention products that also provide activity against hookworms, such as those containing milbemycin oxime or moxidectin [1, 21, 22]. Monthly administration of such products can prevent the establishment of adult worm burdens and reduce egg shedding [1]. Additionally, rapid removal of feces from the environment prevents egg accumulation and larval development [27]. Kennels with documented MDR hookworms should implement strict quarantine protocols for incoming animals and treat all dogs with a combination product at entry [1, 5].

In regions where A. caninum is highly prevalent, such as tropical and subtropical areas, routine fecal examination every 3 to 6 months is recommended for early detection of resistance [28, 29]. Serological and molecular surveys have identified high infection rates in some populations [29, 13].

Conclusion

Ancylostoma caninum hookworm disease remains a significant cause of morbidity in dogs worldwide. The recognition of widespread multidrug resistance, particularly in kennel environments, has fundamentally changed the approach to diagnosis and treatment. Molecular diagnostics, including species-specific qPCR and benzimidazole resistance marker assays, now play an essential role in guiding therapy. Clinicians must adopt evidence-based combination treatment protocols, confirm therapeutic efficacy with FECRT, and implement rigorous environmental control measures to mitigate the spread of resistant hookworm populations.

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

References

[1] Kaplan RM, Jimenez Castro PD, Marsh AE et al. American Association of Veterinary Parasitologists Hookworm Task Force review on best practices for diagnosis and treatment of multidrug-resistant hookworms. J Am Vet Med Assoc. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42102862/

[2] Fagundes-Moreira R, Bezerra-Santos MA, Alves MH et al. Ancylostoma caninum and Uncinaria stenocephala hookworms: Morphological and molecular differentiation and epidemiological data in Southern Italy. Vet Parasitol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40829491/

[3] Traub RJ, Zendejas-Heredia PA, Massetti L et al. Zoonotic hookworms of dogs and cats - lessons from the past to inform current knowledge and future directions of research. Int J Parasitol. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34748782/

[4] Gottstein B, Ising S, Stoye M. [Parasitologic, clinical, hematologic and serologic findings in puppies after lactogenic infection with Ancylostoma caninum ERCOLANI 1859 (Ancylostomidae)]. Zentralbl Veterinarmed B. 1991. URL: https://pubmed.ncbi.nlm.nih.gov/1853668/

[5] Jimenez Castro PD, Durrence K, Durrence S et al. Multiple anthelmintic drug resistance in hookworms (Ancylostoma caninum) in a Labrador breeding and training kennel in Georgia, USA. J Am Vet Med Assoc. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/36520649/

[6] Jimenez Castro PD, Venkatesan A, Redman E et al. Multiple drug resistance in hookworms infecting greyhound dogs in the USA. Int J Parasitol Drugs Drug Resist. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34492564/

[7] Jimenez Castro PD, Howell SB, Schaefer JJ et al. Multiple drug resistance in the canine hookworm Ancylostoma caninum: an emerging threat? Parasit Vectors. 2019. URL: https://pubmed.ncbi.nlm.nih.gov/31818311/

[8] Krämer F, Epe C, Mencke N. Investigations into the prevention of neonatal Ancylostoma caninum infections in puppies by application of imidacloprid 10% plus moxidectin 2.5% topical solution to the pregnant dog. Zoonoses Public Health. 2009. URL: https://pubmed.ncbi.nlm.nih.gov/18793274/

[9] Burke TM, Roberson EL. Fenbendazole treatment of pregnant bitches to reduce prenatal and lactogenic infections of Toxocara canis and Ancylostoma caninum in pups. J Am Vet Med Assoc. 1983. URL: https://pubmed.ncbi.nlm.nih.gov/12002591/

[10] Becskei C, Thys M, Kryda K et al. Efficacy of Simparica Trio™, a novel chewable tablet containing sarolaner, moxidectin and pyrantel, against induced hookworm infections in dogs. Parasit Vectors. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32113471/

[11] Leutenegger CM, Lozoya CE, Tereski J et al. Comparative study of a broad qPCR panel and centrifugal flotation for detection of gastrointestinal parasites in fecal samples from dogs and cats in the United States. Parasit Vectors. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37587483/

[12] Schmidt EM, Tvarijonaviciute A, Martinez-Subiela S et al. Changes in biochemical analytes in female dogs with subclinical Ancylostoma spp. infection. BMC Vet Res. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/27623952/

[13] Dias SR, Cunha DE, da Silva SM et al. Evaluation of parasitological and immunological aspects of acute infection by Ancylostoma caninum and Ancylostoma braziliense in mixed-breed dogs. Parasitol Res. 2013. URL: https://pubmed.ncbi.nlm.nih.gov/23494155/

[14] Visscher D, Porter E, Sweet S et al. Canine nematode and Giardia spp. infections in dogs in Edmonton, Alberta, the "CANIDA" study. Parasit Vectors. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35996178/

[15] Sweet S, Hegarty E, McCrann DJ et al. A 3-year retrospective analysis of canine intestinal parasites: fecal testing positivity by age, U.S. geographical region and reason for veterinary visit. Parasit Vectors. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/33743787/

[16] Wang M, Hang J, Abuzeid AMI et al. Development of multi-ARMS-qPCR method for detection of hookworms from cats and dogs. Parasitol Int. 2019. URL: https://pubmed.ncbi.nlm.nih.gov/31421266/

[17] Fu Y, Wang M, Yan X et al. T(m)-Shift Detection of Dog-Derived Ancylostoma ceylanicum and A. caninum. Biomed Res Int. 2018. URL: https://pubmed.ncbi.nlm.nih.gov/29862291/

[18] Evason M, DeBess E, Culwell N et al. Hookworm Anthelmintic Resistance: Novel Fecal Polymerase Chain Reaction Ancylostoma caninum Benzimidazole Resistance Marker Detection in a Dog. J Am Anim Hosp Assoc. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38394692/

[19] Evason MD, Weese JS, Polansky B et al. Emergence of canine hookworm treatment resistance: Novel detection of Ancylostoma caninum anthelmintic resistance markers by fecal PCR in 11 dogs from Canada. Am J Vet Res. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37442544/

[20] Loukas A, Dowd AJ, Prociv P et al. Purification of a diagnostic, secreted cysteine protease-like protein from the hookworm Ancylostoma caninum. Parasitol Int. 2000. URL: https://pubmed.ncbi.nlm.nih.gov/11077267/

[21] Reinemeyer CR, Faulkner CT, Assadi-Rad AM et al. Comparison of the efficacies of three heartworm preventives against experimentally induced infections with Ancylostoma caninum and Toxocara canis in pups. J Am Vet Med Assoc. 1995. URL: https://pubmed.ncbi.nlm.nih.gov/7782242/

[22] Blagburn BL, Hendrix CM, Lindsay DS et al. Efficacy of milbemycin oxime against naturally acquired or experimentally induced Ancylostoma spp and Trichuris vulpis infections in dogs. Am J Vet Res. 1992. URL: https://pubmed.ncbi.nlm.nih.gov/1586020/

[23] Wade CG, Mercer SH, Hepler DI et al. Effect of milbemycin oxime against Ancylostoma caninum in dogs with naturally acquired infection. Am J Vet Res. 1991. URL: https://pubmed.ncbi.nlm.nih.gov/1883101/

[24] Bowman DD, Rock T, Heaney K et al. Persistent efficacy of moxidectin canine sustained-release injectable against experimental infections of Ancylostoma caninum and Uncinaria stenocephala in dogs. Vet Ther. 2003. URL: https://pubmed.ncbi.nlm.nih.gov/15136983/

[25] Charles S, Deuster K, Wang X et al. Efficacy of a novel chewable tablet (Credelio Quattro™) containing lotilaner, moxidectin, praziquantel, and pyrantel for the treatment and control of hookworm infections in dogs. Parasit Vectors. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40176170/

[26] Snyder DE, Wiseman S, Crawley E et al. Effectiveness of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio(®) Plus) for the treatment of larval and immature adult stages of Ancylostoma caninum in experimentally infected dogs. Parasit Vectors. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34001200/

[27] Ochoa SJ, Hanzlicek GA, Miller KR et al. Survey on canine hookworms: Knowledge, perceptions and practices among U.S. veterinarians. Res Vet Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39657407/

[28] Kim J, Lucio-Forster A, Ketzis JK. Ancylostoma in dogs in the Caribbean: a review and study from St. Kitts, West Indies. Parasit Vectors. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35449121/

[29] Dos Santos B, da Silva ANF, Mora SEV et al. Epidemiological aspects of Ancylostoma spp. infection in naturally infected dogs from São Paulo state, Brazil. Vet Parasitol Reg Stud Reports. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/33308717/

[30] Stracke K, Jex AR, Traub RJ. Zoonotic Ancylostomiasis: An Update of a Continually Neglected Zoonosis. Am J Trop Med Hyg. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32342850/